Koalas vaccinated against Koala retrovirus respond by producing increased levels of interferon-gamma

被引:3
|
作者
Olagoke, Olusola [1 ]
Quigley, Bonnie L. [1 ]
Timms, Peter [1 ]
机构
[1] Univ Sunshine Coast, Genecol Res Ctr, Sunshine Coast, Qld, Australia
基金
澳大利亚研究理事会;
关键词
Koala retrovirus; Vaccination; Immune response; mRNA; NanoString;
D O I
10.1186/s12985-020-01442-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Koala retrovirus (KoRV) is believed to be in an active state of endogenization into the koala genome. KoRV is present as both an endogenous and exogenous infection in all koalas in northern Australia. KoRV has been linked to koala pathologies including neoplasia and increased susceptibility to Chlamydia. A KoRV vaccine recently trialled in 10 northern koalas improved antibody response and reduced viral load. This communication reports the expression of key immune genes underlining the innate and adaptive immune response to vaccination in these northern koalas. The results showed that prior to vaccination, IL-8 was expressed at the highest levels, with at least 200-fold greater expression compared to other cytokines, while CD8 mRNA expression was significantly higher than CD4 mRNA expression level. Interferon-gamma was up-regulated at both 4- and 8-weeks post-vaccination while IL-8 was down-regulated at 8-weeks post-vaccination.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] INTERFERON-GAMMA IS AN OBLIGATORY LYMPHOKINE FOR ANTIBODY-PRODUCING B-CELLS
    ALKAN, SS
    HUEGLI, G
    BRAUN, R
    KENNEDY, M
    ERB, P
    JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 693 - 693
  • [42] OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa
    Ding, Bin
    von Specht, Bernd-Ulrich
    Li, Yuanyi
    VACCINE, 2010, 28 (25) : 4119 - 4122
  • [43] Rifampin levels, interferon-gamma release and outcome in complicated pulmonary tuberculosis
    McIlleron, Helen
    Watkins, Marcia L.
    Folb, Peter I.
    Ress, Stanley R.
    Wilkinson, Robert J.
    TUBERCULOSIS, 2007, 87 (06) : 557 - 564
  • [44] EFFECT OF MURINE RECOMBINANT INTERFERON-GAMMA IN THE PROTECTION OF MICE AGAINST SALMONELLA
    MATSUMURA, H
    ONOZUKA, K
    TERADA, Y
    NAKANO, Y
    NAKANO, M
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1990, 12 (01): : 49 - 56
  • [45] Epitope determination for antibodies raised against recombinant human interferon-gamma
    Hooker, AD
    Green, NH
    James, DC
    Strange, PG
    Baines, AJ
    Bull, AT
    Jenkins, N
    ANIMAL CELL TECHNOLOGY: FROM VACCINES TO GENETIC MEDICINE, 1997, : 277 - 282
  • [46] INTERFERON-GAMMA LEVELS IN PERITONEAL-DIALYSIS EFFLUENTS - RELATION TO PERITONITIS
    DASGUPTA, MK
    LARABIE, M
    HALLORAN, PF
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 475 - 481
  • [47] INTERFERON-GAMMA LEVELS IN THE ODONTOGENIC CYST FLUIDS REGARDING BACTERIUM CONTENT
    Cinar, Suzan
    Ciftci, Sevgi
    Keskin, Fahriye
    Cakarer, Sirmahan
    Selvi, Firat
    Can, Taylan
    Keskin, Cengizhan
    Deniz, Gunnur
    JOURNAL OF ISTANBUL UNIVERSITY FACULTY OF DENTISTRY, 2014, 48 (03) : 17 - 25
  • [48] Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity
    Hozumi, Hiroaki
    Asanuma, Masato
    Miyazaki, Ikuko
    Fukuoka, Saki
    Kikkawa, Yuri
    Kimoto, Naotaka
    Kitamura, Yoshihisa
    Sendou, Toshiaki
    Kita, Taizou
    Gomita, Yutaka
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 175P - 175P
  • [49] ELEVATED PLASMA-CORTISOL LEVELS DURING INTERFERON-GAMMA TREATMENT
    SPATHSCHWALBE, E
    PORZSOLT, F
    DIGEL, W
    BORN, J
    KLOSS, B
    FEHM, HL
    IMMUNOPHARMACOLOGY, 1989, 17 (03): : 141 - 145
  • [50] MONOCLONAL-ANTIBODIES AGAINST THE HUMAN INTERFERON-GAMMA RECEPTOR(S)
    DEPLA, E
    DELEY, M
    MOLECULAR IMMUNOLOGY, 1990, 27 (08) : 745 - 750